blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2476415

EP2476415 - Treating bone-related disorders with selective androgen receptor modulators [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.08.2013
Database last updated on 19.07.2024
Most recent event   Tooltip16.08.2013Application deemed to be withdrawnpublished on 18.09.2013  [2013/38]
Applicant(s)For all designated states
University of Tennessee Research Foundation
UT Conference Center
Suite 211
600 Henley Street
Knoxville, TN 37996-4122 / US
[N/P]
Former [2012/29]For all designated states
University of Tennessee Research Foundation
UT Conference Center Suite 211 600 Henley Street
Knoxville, TN 37996-4122 / US
Inventor(s)01 / Dalton, James
9896 Rue Bienville Place
Lakeland TN 38002 / US
02 / Miller, Duane D.
8706 Maple Creek Cove
Germantown, TN 38139 / US
03 / Steiner, Mitchell S.
8894 Silver Bark Drive
Germantown, TN 38138 / US
04 / Veverka, Karen A.
669 Featherwind Cove, S.
Cordova, TN 38018 / US
05 / Kearby, Jeffrey
1835 Galleon Blvd.
Hilliard, OH 43024 / US
 [2012/33]
Representative(s)Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
[N/P]
Former [2013/01]Pearl Cohen Zedek Latzer UK LLP
15 Old Bailey
London EC4M 7EF / GB
Former [2012/29]Lord, Hilton David
Marks & Clerk LLP
90 Long Acre
London
WC2E 9RA / GB
Application number, filing date12161224.612.10.2004
[2012/29]
Priority number, dateUS20030510138P14.10.2003         Original published format: US 510138 P
US20040613206P28.09.2004         Original published format: US 613206 P
[2012/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2476415
Date:18.07.2012
Language:EN
[2012/29]
Type: A3 Search report 
No.:EP2476415
Date:29.08.2012
Language:EN
[2012/35]
Search report(s)(Supplementary) European search report - dispatched on:EP26.07.2012
ClassificationIPC:A61K31/167, A61P19/08, A61P19/10, A61P3/00, A61P5/00, A61K31/00, A61K31/165, A61K31/21, A61K31/32, A61K31/405, A61K31/4704, A61K31/66
[2012/29]
CPC:
A61K31/167 (EP,US); A61K31/00 (EP,US); A61K31/165 (EP,US);
A61K31/21 (EP,US); A61K31/32 (EP,US); A61K31/405 (EP,US);
A61K31/4704 (EP,US); A61K31/66 (EP,US); A61P19/00 (EP);
A61P19/08 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P3/00 (EP); A61P3/14 (EP); A61P5/00 (EP);
A61P5/24 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/29]
Extension statesAL26.03.2012
HR26.03.2012
LT26.03.2012
LV26.03.2012
MK26.03.2012
TitleGerman:Behandlung von Knochenerkrankungen mit selektiven androgenen Rezeptormodulatoren[2012/29]
English:Treating bone-related disorders with selective androgen receptor modulators[2012/29]
French:Traitement des troubles osseux avec des modulateurs sélectifs de récepteurs d'androgène[2012/29]
Examination procedure26.03.2012Examination requested  [2012/29]
01.03.2013Application deemed to be withdrawn, date of legal effect  [2013/38]
18.04.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/38]
Parent application(s)   TooltipEP04809913.9  / EP1673376
Fees paidRenewal fee
26.03.2012Renewal fee patent year 03
26.03.2012Renewal fee patent year 04
26.03.2012Renewal fee patent year 05
26.03.2012Renewal fee patent year 06
26.03.2012Renewal fee patent year 07
26.03.2012Renewal fee patent year 08
11.10.2012Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2004034978  (GTX INC [US], et al) [XP] 1-7 * pages 56-58; example 2 * * figure - ** claims 52-61,73-82 *;
 [XP]WO2004064747  (GTX INC [US], et al) [XP] 1-7 * figures 4-5; examples 3 p 59-64; claim - *
by applicant   - WAHNER H W ET AL., Nuclear Medicine: ''Quantitative Procedures, TORONTO LITTLE, BROWN & CO., (1983), pages 107 - 132
    - "Assessment of Bone Mineral Part I", J NUCL MEDICINE, (1984), pages 1134 - 1141
    - "Bone Mineral Density of The Radius", J NUCL MEDICINE, (1985), vol. 26, pages 13 - 39
    - KALU DN, BONE MINER, (1991), vol. 15, pages 175 - 91
    - FAULKNER KG ET AL., AM J ROENTGENOLOGY, (1991), vol. 157, pages 1229 - 1237
    - LANGER, SCIENCE, (1990), vol. 249, pages 1527 - 1533
    - TREAT ET AL., Liposomes in the Therapy of Infectious Disease and Cancer, LISS, (1989), pages 353 - 365
    - LIPOSOMES IN THE THERAPY OF INFECTIOUS DISEASE AND CANCER, pages 317 - 327
    - SEFTON, CRC CRIT. REF. BIOMED. ENG., (1987), vol. 14, page 201
    - BUCHWALD ET AL., SURGERY, (1980), vol. 88, page 507
    - SAUDEK ET AL., N. ENGL. J. MED., (1989), vol. 321, page 574
    - GOODSON, MEDICAL APPLICATIONS OF CONTROLLED RELEASE, (1984), vol. 2, pages 115 - 138
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.